Latest Equities News

DGR Global lodged a key director interest notice 14 days late due to an administrative slip, prompting an ASX compliance query. The company has outlined its existing governance measures and pledged refresher training to tighten disclosure controls.

Nexalis Therapeutics (ASX: NX1) has voluntarily suspended trading of its shares pending a material announcement on its existing debt funding facility, extending a recent trading halt. The suspension is set to last until the earlier of the announcement release or resumption of trading on 28 May 2026.

Magnetite Mines initiates a leadership overhaul and strategic reset to cut costs and pursue phased development of its Razorback Iron Ore Project amid challenging market conditions.

Brightstar Resources has given the green light to its Goldfields Project, commencing construction of a 1.5Mtpa processing plant at Laverton. First gold production is slated for June 2027, backed by full funding and regulatory approvals.

Urbanise.com Limited appoints Darc Rasmussen as Executive Chairman, unveils an AI Assistant for strata managers, and converts two legacy system customers with new contracts worth $700k over three years.

St Barbara Limited has secured final investment decisions for its New Simberi expansion in Papua New Guinea and the Touquoy Restart in Nova Scotia, targeting a production surge exceeding 200% over the next four years.

Challenger Limited unveiled a strategic blueprint at its 2026 Investor Day, leveraging demographic shifts and regulatory reforms to cement its leadership in Australia’s retirement income sector.

Goodman NZ surged to a $248 million statutory profit in FY26, propelled by strong property revaluations and leasing gains, while advancing major development projects and transitioning to a stapled group structure.

Fisher & Paykel Healthcare posted a 14% revenue increase to NZ$2.31 billion and a 24% rise in net profit to NZ$468.5 million for FY2026, driven by strong hospital product sales and ongoing innovation.

Infratil posted an 11% rise in operational EBITDAF to NZ$989 million in FY26, fuelled by a record 555MW CDC data centre contract and a 170% EBITDAF jump at Longroad Energy. The company refined its portfolio with over NZ$600 million in divestments and secured a BBB+ credit rating, underpinning a strong FY27 outlook.

Sandon Capital is seeking noteholder approval to amend its 4.8% unsecured notes, offering an 8.5% fixed interest extension and monthly payments, alongside a $10 million conditional note placement.

Thrive Tribe Technologies’ 1TTO securities face immediate suspension from ASX pending regulatory compliance, isolating the impact to this class alone amid ongoing capital raises.